IGMS - Wall Street Estimates - IGM Biosciences, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 1.29

-5.15 %

$ 76.7 M

Market Cap

-0.36

P/E

Price Target Average

1067.10%

Revenue Forecast Estimate

192.63%

EBIT Estimate

26.84%

Net Income Estimate

47.18%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets IGM Biosciences, Inc.

Wall Street analysts predict an average 1-year price target for IGMS of $15.1 , with forecasts ranging from a low of $1.5 to a high of $25 .

IGMS Lowest Price Target Wall Street Target

1.5 USD 16.28%

IGMS Average Price Target Wall Street Target

15.1 USD 1067.10%

IGMS Highest Price Target Wall Street Target

25 USD 1837.98%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free